Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Genome Research Limited investment portfolio
Genome Research Limited has made numerous investments in companies such as Mosaic Therapeutics, Microbiotica, and Kymab Group within the Biotech sector.
Portfolio
4
Team
0
Ownership Chain
Sign up free to see the Persons with Significant Control resolved from Companies House.
Sign up freePortfolio (4)
| Company | Sector | City | Source | Last confirmed on |
|---|---|---|---|---|
| Ensocell Ltd Ensocell Ltd is a biotechnology company that develops next‑generation precision biologic therapies for autoimmune and fibrotic diseases, using its single‑cell genomics‑based Ensight platform and AI‑driven computational tools. | Healthcare & Life Sciences | Cambridge | Confirmed | 2026-03-07 |
| Kymab Group Limited Kymab Group Limited develops monoclonal antibody therapeutics for the treatment of cancer, inflammatory diseases and other medical conditions, supplying its products to pharmaceutical partners and the broader healthcare market. | — | Cambridge | Confirmed | 2025-09-23 |
Articles (1)
- Mosaic Therapeutics Secures £261.4k Growth Funding Amidst Evolving UK Biotech Landscape24 Apr 2026Mosaic Therapeutics